Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The key role of Warburg effect in SARS-CoV-2 replication and associated inflammatory response
Philippe Icard, Hubert Lincet, Zherui Wu, et al.
Biochimie (2020) Vol. 180, pp. 169-177
Open Access | Times Cited: 119

Showing 1-25 of 119 citing articles:

Mitochondria-mediated oxidative stress during viral infection
J.T.W. Foo, Grégory Bellot, Shazib Pervaiz, et al.
Trends in Microbiology (2022) Vol. 30, Iss. 7, pp. 679-692
Open Access | Times Cited: 179
‘Warburg effect’ controls tumor growth, bacterial, viral infections and immunity – Genetic deconstruction and therapeutic perspectives
Jacques Pouysségur, Ibtissam Marchiq, Scott K. Parks, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 334-346
Open Access | Times Cited: 90
SARS-CoV-2 Infects Human Pluripotent Stem Cell-Derived Cardiomyocytes, Impairing Electrical and Mechanical Function
Silvia Marchianò, Tien-Ying Hsiang, Akshita Khanna, et al.
Stem Cell Reports (2021) Vol. 16, Iss. 3, pp. 478-492
Open Access | Times Cited: 99
Metabolic Perturbation Associated With COVID-19 Disease Severity and SARS-CoV-2 Replication
Shuba Krishnan, Hampus Nordqvist, Anoop T. Ambikan, et al.
Molecular & Cellular Proteomics (2021) Vol. 20, pp. 100159-100159
Open Access | Times Cited: 97
Antiviral strategies targeting host factors and mechanisms obliging +ssRNA viral pathogens
Supreeti Mahajan, Shweta Choudhary, Pravindra Kumar, et al.
Bioorganic & Medicinal Chemistry (2021) Vol. 46, pp. 116356-116356
Open Access | Times Cited: 81
Changes in Glycolytic Pathway in SARS-COV 2 Infection and Their Importance in Understanding the Severity of COVID-19
Adalberto Santos, Pedro Póvoa, Paulo Paixão, et al.
Frontiers in Chemistry (2021) Vol. 9
Open Access | Times Cited: 59
Historical perspective of tumor glycolysis: A century with Otto Warburg
Giulia Bononi, Samuele Masoni, Valeria Di Bussolo, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 325-333
Open Access | Times Cited: 44
Pathophysiological involvement of host mitochondria in SARS-CoV-2 infection that causes COVID-19: a comprehensive evidential insight
Chandan Bhowal, Sayak Ghosh, Debapriya Ghatak, et al.
Molecular and Cellular Biochemistry (2022) Vol. 478, Iss. 6, pp. 1325-1343
Open Access | Times Cited: 44
Inflammatory pathways in COVID‐19: Mechanism and therapeutic interventions
Yujie Jiang, Tingmei Zhao, Xueyan Zhou, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 42
The pyruvate dehydrogenase complex: Life’s essential, vulnerable and druggable energy homeostat
Peter W. Stacpoole, Charles E. McCall
Mitochondrion (2023) Vol. 70, pp. 59-102
Open Access | Times Cited: 29
Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection
Peiran Chen, Mandi Wu, Yaqing He, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 27
Deciphering the Relationship between SARS-CoV-2 and Cancer
Michele Costanzo, Maria Anna Rachele De Giglio, Giovanni N. Roviello
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7803-7803
Open Access | Times Cited: 22
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Amr E. Abbas, Fatima Abbas, et al.
The Lancet Diabetes & Endocrinology (2023) Vol. 11, Iss. 12, pp. 905-914
Open Access | Times Cited: 21
Anti-Warburg Effect of Melatonin: A Proposed Mechanism to Explain its Inhibition of Multiple Diseases
Rüssel J. Reiter, Ramaswamy Sharma, Sergio Rosales‐Corral
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 764-764
Open Access | Times Cited: 51
Molecular and Biological Mechanisms Underlying Gender Differences in COVID-19 Severity and Mortality
Zena Wehbe, Safaa Hisham Hammoud, Hadi M. Yassine, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 43
1H qNMR-Based Metabolomics Discrimination of Covid-19 Severity
Banny Silva Barbosa Correia, Vinícius Guimarães Ferreira, Priscila M. F. D. Piagge, et al.
Journal of Proteome Research (2022) Vol. 21, Iss. 7, pp. 1640-1653
Closed Access | Times Cited: 27
Oxaloacetate Treatment For Mental And Physical Fatigue In Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long-COVID fatigue patients: a non-randomized controlled clinical trial
Alan Cash, David L. Kaufman
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 27
COVID-19-Induced Diabetes Mellitus: Comprehensive Cellular and Molecular Mechanistic Insights
Praise Tatenda Nhau, Mlindeli Gamede, Ntethelelo Sibiya
Pathophysiology (2024) Vol. 31, Iss. 2, pp. 197-209
Open Access | Times Cited: 6
Influence of COVID-19 on biochemical and endocrine profiles of patients with and without type 2 diabetes and/or obesity
Shivani Jaiswal, Vandana Dhiman, Rahul Tiwari, et al.
International Journal of Diabetes in Developing Countries (2025)
Closed Access
Glycolysis in asthma: Its role and potential as a diagnostic or therapeutic target
Xuejiao Lv, Wenrui Wang, Hongna Dong, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114143-114143
Open Access
Comparative metabolomic analysis reveals shared and unique features of COVID-19 cytokine storm and surgical sepsis
Iana Russkikh, О. С. Попов, Tatiana G. Klochkova, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Delayed viral clearance and altered inflammatory responses affect severity of SARS-CoV-2 infection in aged mice
Émile Lacasse, Isabelle Dubuc, Leslie Gudimard, et al.
Immunity & Ageing (2025) Vol. 22, Iss. 1
Open Access
Molecular docking, pharmacological profiling, and MD simulations of glycolytic inhibitors targeting novel SARS CoV-2 main protease and spike protein
Nikhil Kumar, Chandraprakash Gond, Jai Deo Singh, et al.
In Silico Pharmacology (2025) Vol. 13, Iss. 1
Closed Access
Effects of dapagliflozin on prevention of major clinical events and recovery in patients with respiratory failure because of COVID‐19: Design and rationale for the DARE‐19 study
Mikhail Kosiborod, Otávio Berwanger, Gary G. Koch, et al.
Diabetes Obesity and Metabolism (2020) Vol. 23, Iss. 4, pp. 886-896
Open Access | Times Cited: 45
Long Noncoding RNAs as Emerging Regulators of COVID-19
Qinzhi Yang, Lin Fang, Yanan Wang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 38
Page 1 - Next Page

Scroll to top